<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Wu ZQ</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>This study aimed to investigate whether visceral adipose tissue index (VATI) is a significant risk factor for the early recurrence (ER) of HBV-related hepatocellular carcinoma (HCC) (≤5 cm) after hepatectomy.&lt;h4>Methods&lt;/h4>The recruited cohort patients who were positive for hepatitis B virus, presented with surgically confirmed HCC (≤5 cm) from Army Medical University (internal training cohort: &lt;i>n&lt;/i> = 192) and Chongqing Medical University (external validation group: &lt;i>n&lt;/i> = 46). We measured VATI, subcutaneous adipose tissue index (SATI) &lt;i>via&lt;/i> computed tomography (CT). ER was defined as recurrence within 2 years after hepatectomy. The impact of parameters on outcome after hepatectomy for HCC was analyzed.&lt;h4>Results&lt;/h4>Univariate analysis showed that alpha-fetoprotein levels (&lt;i>p&lt;/i> = 0.044), body mass index (BMI) (&lt;i>p&lt;/i> &lt; 0.001), SATI (&lt;i>p&lt;/i> &lt; 0.001), and VATI (&lt;i>p&lt;/i> &lt; 0.001) were significantly different between ER and non-ER groups in internal training cohort. Multivariate analysis identified VATI as an independent risk factor for ER (odds ratio = 1.07, 95% confidence interval: 1.047-1.094, &lt;i>p&lt;/i> &lt; 0.001), with a AUC of 0.802, based on the cut-off value of VATI, which was divided into high risk (≥37.45 cm&lt;sup>2&lt;/sup>/m&lt;sup>2&lt;/sup>) and low risk (&lt;37.45 cm&lt;sup>2&lt;/sup>/m&lt;sup>2&lt;/sup>) groups. The prognosis of low risk group was significantly higher than that of high risk group (&lt;i>p &lt;/i>&lt; 0.001). The AUC value of VATI in external validation group was 0.854.&lt;h4>Conclusion&lt;/h4>VATI was an independent risk factor for the ER, and higher VATI was closely related to poor outcomes after hepatectomy for HBV-related HCC (≤5 cm).</pubmed_abstract><journal>Frontiers in surgery</journal><pagination>985168</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9852492</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Preoperative prediction of early recurrence of HBV-related hepatocellular carcinoma (≤5 cm) by visceral adipose tissue index.</pubmed_title><pmcid>PMC9852492</pmcid><pubmed_authors>Wu ZQ</pubmed_authors><pubmed_authors>Cai P</pubmed_authors><pubmed_authors>Li XM</pubmed_authors><pubmed_authors>Xiao XX</pubmed_authors><pubmed_authors>Zhang HR</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Peng J</pubmed_authors><pubmed_authors>Cheng J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preoperative prediction of early recurrence of HBV-related hepatocellular carcinoma (≤5 cm) by visceral adipose tissue index.</name><description>&lt;h4>Background&lt;/h4>This study aimed to investigate whether visceral adipose tissue index (VATI) is a significant risk factor for the early recurrence (ER) of HBV-related hepatocellular carcinoma (HCC) (≤5 cm) after hepatectomy.&lt;h4>Methods&lt;/h4>The recruited cohort patients who were positive for hepatitis B virus, presented with surgically confirmed HCC (≤5 cm) from Army Medical University (internal training cohort: &lt;i>n&lt;/i> = 192) and Chongqing Medical University (external validation group: &lt;i>n&lt;/i> = 46). We measured VATI, subcutaneous adipose tissue index (SATI) &lt;i>via&lt;/i> computed tomography (CT). ER was defined as recurrence within 2 years after hepatectomy. The impact of parameters on outcome after hepatectomy for HCC was analyzed.&lt;h4>Results&lt;/h4>Univariate analysis showed that alpha-fetoprotein levels (&lt;i>p&lt;/i> = 0.044), body mass index (BMI) (&lt;i>p&lt;/i> &lt; 0.001), SATI (&lt;i>p&lt;/i> &lt; 0.001), and VATI (&lt;i>p&lt;/i> &lt; 0.001) were significantly different between ER and non-ER groups in internal training cohort. Multivariate analysis identified VATI as an independent risk factor for ER (odds ratio = 1.07, 95% confidence interval: 1.047-1.094, &lt;i>p&lt;/i> &lt; 0.001), with a AUC of 0.802, based on the cut-off value of VATI, which was divided into high risk (≥37.45 cm&lt;sup>2&lt;/sup>/m&lt;sup>2&lt;/sup>) and low risk (&lt;37.45 cm&lt;sup>2&lt;/sup>/m&lt;sup>2&lt;/sup>) groups. The prognosis of low risk group was significantly higher than that of high risk group (&lt;i>p &lt;/i>&lt; 0.001). The AUC value of VATI in external validation group was 0.854.&lt;h4>Conclusion&lt;/h4>VATI was an independent risk factor for the ER, and higher VATI was closely related to poor outcomes after hepatectomy for HBV-related HCC (≤5 cm).</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-22T01:11:12.628Z</modification><creation>2025-04-05T19:50:46.716Z</creation></dates><accession>S-EPMC9852492</accession><cross_references><pubmed>36684155</pubmed><doi>10.3389/fsurg.2022.985168</doi></cross_references></HashMap>